Acute
diarrhoea and fever
S Dundas, Consultant Physician, Infectious
Diseases Unit, Monklands District General Hospital, Airdrie, UK
WTA Todd, Consultant Physician, Infectious
Diseases Unit, Monklands District General Hospital, Airdrie, UK
Overview Introduction
Diarrhoeal disease is an important cause of morbidity worldwide and
represents a leading cause of childhood death in the developing world.
In the developed world the mortality rate has fallen sharply due to a
decline in illness caused by Clostridium perfringens and salmonellas.
The elderly remain especially susceptible to the complications of diarrhoea
and account for 85% of related deaths.
Diarrhoea may be defined as acute if present for less than 2
weeks, persistent if present for 2–4 weeks, and chronic
if greater than 4 weeks in duration. Acute diarrhoea and fever may be
the presenting symptoms of a number of underlying conditions and although
infectious agents account for 90% of cases, inflammatory bowel disease,
ischaemic colitis, acute diverticulitis, toxins, medications, and overflow
from constipation should also be considered.
Infectious gastroenteritis
The majority of patients with acute diarrhoea do not seek medical attention,
and investigations are frequently omitted in those who do, therefore the
prevalence of infectious diarrhoea is grossly underestimated. Most cases
are viral with bacterial stool cultures positive in less than 5% of presentations.
Higher rates of stool culture positivity are observed in more severe cases,
those with bloody diarrhoea, and those admitted to hospital.
Patients at increased risk of infectious gastroenteritis include travellers
who have visited tropical or semitropical regions, the elderly, men who
have sex with men, infants, the immunocompromised, or those who have received
antibiotic agents.
In the UK notifications of organisms isolated in infectious gastroenteritis
are collated by the Health Protection Agency and Health Protection Scotland.
Campylobacter spp. (46%) are the most commonly isolated organisms
and account for almost half of confirmed infections. Rotavirus
(19%), small round structured virus (14%), and Salmonella (12%)
infections are confirmed with similar frequencies. Shiga toxin-producing
Escherischia coli (STEC 2%) and Shigella (1%) infections
are infrequent.
Clinical features
A
careful history may determine a possible source of infection, or whether
the diarrhoea is of small or large bowel origin, thereby indicating the
most likely pathogen (see Table
1). Relevant details are the duration of diarrhoea, the frequency
and volume of stools, and the presence of blood or fever. Suspect foods
within relevant incubation periods, recent antibiotic use or travel, hobbies,
pets, medications, and affected contacts should also be considered. Indications
for hospitalisation and investigation include profuse diarrhoea with signs
of hypovolaemia, grossly bloody stools, fever, duration greater than 48
hours without improvement, severe abdominal pain, and diarrhoea in the
elderly or immunocompromised.
Incubation period
Symptoms that begin within six hours suggest the ingestion of preformed
toxin of Staphylococcus aureus or Bacillus cereus. Symptoms
that occur 8–14 hours after ingestion suggest C. perfringens.
Symptoms that begin more than 14 hours after ingestion can result from
viral or bacterial infection.
Fever
Fever suggests infection with invasive bacteria such as Campylobacter,
Salmonella, or Shigella, enteric viruses, or a cytotoxin-producing
organism such as Clostridium difficile or STEC.
Diarrhoea
The enteric locus of infection and the dominant pathogenic process will
determine the clinical presentation.
Acute dysentery is defined as frequent, small bowel movements accompanied
by blood and mucous with tenesmus or pain on defecation. The syndrome
implies inflammatory invasion of the colonic mucosa and in this context
invasive bacteria such as Campylobacter, Shigella, and STEC are
the most likely causes. Faecal leukocytes are present. The epidemiological
patterns of acute dysentery are influenced by the low inoculum required
for infection and consequently there is a high risk of person-to-person
spread.
Large volume watery diarrhoea and diffuse abdominal cramps are typical
of small intestinal infection. There is only a modest increase in the
number of stools because the colonic reservoir is intact. This is a non-inflammatory
process confirmed by the absence of faecal leukocytes. The diarrhoea is
mediated by bacterial enterotoxins that alter fluid and electrolyte transport
(Vibrio cholerae, enterotoxigenic E. coli, enteropathogenic
E. coli, Salmonella spp., Cryptosporidium, Clostridium
perfringens, Bacillus cereus) or organisms that characteristically
affect the proximal small bowel (Giardia lamblia, Rotavirus, Norovirus:
previously known as Norwalk agent).
Investigations
Faecal leukocytes
The ability of faecal leukocytes to predict inflammatory diarrhoea has
varied greatly, with reported sensitivity and specificity ranging from
20–90%. Consequently, it is not recommended as a routine investigation
of diarrhoea.
Stool cultures
Stool culture is important in those with severe illness, the immunocompromised,
and for employees such as food handlers, who require negative stools to
return to work. A routine culture will identify Campylobacter, Salmonella,
and Shigella. Culture for Shiga toxin-producing organisms such
as E. coli O157, although requiring a specific McConkey sorbital
medium, is now carried out routinely in the UK. Bacterial pathogens are
excreted continuously and a negative result is generally accurate. Stool
cultures are of little value in those developing diarrhoea following more
than 72 hours hospitalisation, in whom stool examination for C. difficile
toxin is a much more relevant investigation.
Routine stool examination for ova, cysts, and parasites (OCP), such as
Giardia, Cryptosporidium, Cyclospora, Entamoeba histolytica,
is not cost effective. Stools should be investigated for OCP in cases
of persistent diarrhoea, patients who have travelled to an endemic area
such as Eastern Europe, within a community water-borne outbreak, in men
who have sex with men, and in cases of bloody diarrhoea where amoebiasis
is suspected. Due to the intermittent excretion of OCP three stool specimens
should be sent on consecutive days.
Further investigation
Flexible sigmoidoscopy or colonoscopy are rarely indicated but may be
required to identify inflammatory bowel disease or ischaemic colitis,
and in immunocompromised patients. Additional investigations are determined
by the most likely pathology, and abdominal CT, barium enema, or isotope-labelled
white cell scan may be required in specific circumstances.
Management
All suspected infective cases require single-room isolation with ‘enteric’
precautions.
Fluid and electrolyte replacement constitutes the cornerstone of treatment
of diarrhoeal illness. Intravenous rehydration is grossly overused and
rehydration should preferably be by the oral route with solutions that
contain water, salt, and sugar. Antimotility agents should be avoided
as they may exacerbate or prolong symptoms.
In otherwise healthy patients there is a lack of benefit from antibiotic
therapy. The British Infection Society has identified patients with ‘high
risk criteria’ for whom antibiotics should be considered on admission.
These are:
- Age >60 years
- Reduced gastric acid
- Immunocompromised
- Significant co-morbidity
- Elevated white cell count
- Fever or bloody diarrhoea
The duration of gastroenteritis and the most likely organism should also
be taken into consideration. If criteria for antibiotic therapy are met,
oral ciprofloxacin, to which the majority of isolates remain susceptible,
is generally recommended.
Important organisms
Viral
infections
Thirty to forty per cent of all acute episodes of gastroenteritis are
caused by viruses, which may be grouped into four categories: Rotavirus,
enteric adenovirus, astrovirus, and calicivirus (including Norovirus)
(see Figure
1).
Norovirus infections have become the most important cause of
institutional, particularly healthcare-associated, outbreaks of gastroenteritis
and are difficult to contain. A large human reservoir of infection, a
very low infectious dose, and the ability to be transmitted by a variety
of routes, including aerosol and faecal-oral, contribute to the impact
of the disease. Infection by this virus has now become the most common
cause of gastroenteritis in adults in the UK. A new genotype (2.4) has
emerged recently and the previous clear winter peak has changed with the
loss of the seasonal characteristic. Generally there is little merit in
sending stools for viral cultures or PCR as knowing the identity of the
virus does not alter management, which involves careful infection control
and supportive fluids as above.
Bacterial pathogens
The
annual number of cases of notified gastroenteritis by causative organism
is shown in Figure
2.
Campylobacter
Campylobacter is now the most common cause of bacterial infective
gastroenteritis in the UK. Infection is transmitted from raw or undercooked
meat, especially poultry, and is often linked to fast food outlets, unpasteurised
milk, and domestic pets with diarrhoea. Person-to-person transmission
is unusual. The organism does not multiply in food and food-borne outbreaks
are rare. The incubation period is 2–5 days. Presentation is usually
with abdominal pain and bloody diarrhoea, vomiting is uncommon. Campylobacter
may be confused with ulcerative colitis or Crohn’s disease and findings
on rectal biopsy are not specific. Toxic megacolon has been reported and
may necessitate colectomy. Transient bacteraemia occurs in 1% of infections
and does not require specific treatment in the immunocompetent host. The
majority of patients do not require antibiotics and although patients
with ‘high risk’ features are usually treated with ciprofloxacin,
significant resistance is emerging and recommendations may change.
Salmonella
Salmonella infections have reduced considerably in the UK over
the last decade largely due to rigorous management of infection in poultry
flocks. Transmission is predominantly from red and white meats, raw or
undercooked eggs, milk, and dairy products. Person-to-person spread is
common during the diarrhoeal phase of illness. Salmonellosis presents
with watery diarrhoea, vomiting, and fever. Blood cultures are positive
in 1–4% of infections and the elderly and the immunocompromised
are at increased risk of both bacteraemia and metastatic infection. Endovascular
infection occurs in 10–25% of persons over 50 years of age, usually
involves the aorta, and most commonly results from seeding of atherosclerotic
plaques or aneurysms. Mortality rates from endovascular infection range
from 14–60% and are lower with prompt diagnosis and combined medical
and surgical therapy. Ciprofloxacin is the antibiotic of choice for ‘high
risk’ patients with severe gastrointestinal infection and bacteraemia.
Prolonged antibiotic therapy is required for endovascular infection. Following
the resolution of gastrointestinal symptoms the mean duration of carriage
is 4–5 weeks but may be prolonged by antibiotic therapy.
Shiga-toxin producing E. coli (STEC)
STEC infections such as E. coli O157, although infrequent,
attract significant attention because of potentially serious complications,
particularly the haemolytic uraemic syndrome (HUS). Transmission is from
undercooked ground beef, water, and cross-contamination of cooked products.
The low infectious dose of STEC strains, estimated to be less than 100
organisms, facilitates transmission. Gastrointestinal symptoms range from
mild diarrhoea to haemorrhagic colitis with often dominant and severe
abdominal pain.
Haemolytic uraemic syndrome develops in 10% of patients overall, with
children under the age of five and the elderly most at risk. Haemolytic
uraemic syndrome is characterised by acute renal failure, haemolytic anaemia,
and thrombocytopenia. Although the kidneys are the most vulnerable target
organs, any tissue may be affected. Mortality rates following HUS have
improved recently but remain around 5% in children and more in the elderly
due to an increased incidence of neurological complications. Antibiotics
should be avoided, as there is some evidence that they may promote the
release of Shiga toxin and increase the risk of HUS.
Clostridium difficile-associated diarrhoea
Clostridium difficile-associated diarrhoea (CDAD) usually occurs
4–9 days after starting antibiotics, and almost all antibiotics
have now been implicated in causation. It predominantly affects frail
elderly people in whom the mortality rate may be as high as 25%. Clinical
severity varies from mild watery diarrhoea to severe bloody diarrhoea.
Complications include hypovolaemic shock, toxic megacolon, perforation,
haemorrhage, and sepsis. C. difficile is spread indirectly by
the faecal-oral route via spores left on surfaces. CDAD is characterised
by progression from an uncolonised state through to C. difficile
colonisation followed by, in response to antibiotic pressure, toxin production.
Asymptomatic colonisation occurs in over 20% of hospital patients and
UK infection rates are increasing exponentially, particularly in vulnerable
hospitalised patients.
To eradicate CDAD oral metronidazole, 400 mg every 8 hours, is the treatment
of choice. Oral vancomycin, in an initial dose of 125 mg every 6 hours,
is at least as effective as metronidazole but in view of its greater cost
should be reserved for those who have failed to respond to metronidazole
or for the severely unwell patient. If patients are unable to take oral
medications a nasogastric tube is necessary because the enteral route
is required to treat infection. Current antibiotic therapy should be withdrawn
if possible. Evidence is inadequate to support the use of prebiotics or
probiotics for treatment of established CDAD.
HIGHLIGHTS
-
All cases of acute diarrhoea must be considered infective until
proven otherwise and managed in appropriate single-room isolation
with ‘enteric precautions’.
-
The incidence of the well-known pathogens in the aetiology of
food poisoning/acute gastroenteritis has changed significantly in
the last decade.
-
In adults, viral gastroenteritis due to Norovirus has
become a major cause of institutional outbreaks of diarrhoea.
-
Clostridium difficile is an increasingly important cause
of healthcare-associated infection.
-
Diarrhoea and fever as a syndrome has a heterogeneous aetiology
and antibiotics should not be administered unless there are indications
of specific risk or severity.
Further reading
Farthing M, Feldman R, Finch R, et al. The
management of infective gastroenteritis in adults. A consensus statement
by an expert panel convened by the British Society for the Study of Infection.
J Infect 1996; 33(3):143–52.
Riley TV. Nosocomial
diarrhoea due to Clostridium difficile. Curr Opin Infect Dis
2004; 17(4):323–7.
Health Protection Agency
Tarr PI. Escherichia
coli O157:H7: clinical, diagnostic, and epidemiological aspects of human
infection. Clin Infect Dis 1995; 20(1):1–8; quiz 9–10.
© Royal College of Physicians of
Edinburgh, 2007
|